I think they can support up until Malta. We can take that avenue if required, however, and the Latin American announcement/connection gives us a hint of possible alternative supply options if required. 700 patients at $10k per patient pa is still $7m revenue, which is quite impressive after a few months. Let's see how the growth continues, but the recent market expansion only opens us up to stronger growth.
Ann: Approval Received for Distribution of CannEpil into Ireland, page-35
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.31M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $8.413K | 28.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4976 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 32323 | 2 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |